Skip to main content
Clinical Trials/ISRCTN82708510
ISRCTN82708510CompletedNot Applicable

Choline supplementation in postmenopausal women: effects on bone health and risk markers for cardiovascular disease (CVD) - a randomised double-blind placebo-controlled intervention trial

niversity of Ulster (UK)0 sites44 target enrollmentStarted: January 13, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
44

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • 1. Women aged 50 - 70 years
  • 2. Independently mobile
  • 3. Postmenopausal (menopausal status defined as at least 6 months of amenorrhoea within the past year)

Exclusion Criteria

  • 1. Smoking
  • 2. Body mass index (BMI) greater than 35 kg/m^2
  • 3. Hepatic or renal disease
  • 4. Gastrointestinal disease
  • 5. Endocrine or metabolic abnormalities
  • 6. Use of drugs or dietary supplements known to influence B vitamin or choline status or metabolism
  • 7. Haematological disorder
  • 8. Serum vitamin B-12 concentration less than 111pmol/l or serum creatinine concentration greater than or equal to 130 umol/l

Investigators

Sponsor
niversity of Ulster (UK)

Similar Trials